Global IP Exchange Europe: IP leaders’ investment priorities revealed
Ahead of the Global IP Exchange Europe on March 9-11 in Berlin, the event’s organisers surveyed senior executives to find out their IP, patent, trademark, and brand protection investment priorities for the next 6-12 months.
Latest news
Genentech in $1.7bn immuno-oncology deal
27-02-2020
California-headquartered biotech Genentech has agreed to pay $30 million upfront to develop immuno-oncology therapies with UK-based Bicycle Therapeutics.
